Identification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3

Maki Daniels1, Vishal Dhokia, Laurent Richard-Parpaillon

  • 1Department of Oncology, The Hutchison/MRC Research Centre, University of Cambridge, Hills Road, Cambridge, CB2 2XZ, UK.

Gene
|November 6, 2004
PubMed

Insights

Two novel cyclin-dependent kinase (cdk) inhibitors, p16Xic2 and p17Xic3, were identified in Xenopus. These inhibitors regulate cell cycle progression and influence cell fate determination during development.

Area of Science:

  • Developmental Biology
  • Cell Cycle Regulation
  • Molecular Biology

Background:

  • The Cip/Kip family of cyclin-dependent kinase (cdk) inhibitors is crucial for development, regulating cell fate and differentiation.
  • These inhibitors also block cell cycle progression.

Purpose of the Study:

  • To identify and characterize novel members of the Kip/Cip cdk inhibitor family in Xenopus laevis.
  • To investigate the roles of these novel inhibitors in cell cycle control and cell fate determination.

Main Methods:

  • Sequence analysis to identify novel cdk inhibitors.
  • Overexpression studies to assess effects on cell cycle progression and cdk2 activity.
  • Expression pattern analysis during development.
  • Retinal cell fate determination assays.

Main Results:

  • Two novel Xenopus Kip/Cip inhibitors, p16Xic2 and p17Xic3, were identified as orthologues of mammalian p21Cip1 and p27Kip1.
  • Overexpression of p16Xic2 and p17Xic3 caused cell cycle arrest by inhibiting cdk2 activity.
  • Expression of these inhibitors is developmentally regulated and tissue-specific.
  • Both inhibitors influenced cell fate determination in a retinal assay.

Conclusions:

  • p16Xic2 and p17Xic3 are Xenopus cdk inhibitors involved in regulating cell proliferation and differentiation.
  • These inhibitors likely play tissue-specific roles in cell fate determination during development.
  • Their function parallels that of mammalian p27Xic1 in coordinating proliferation and differentiation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...